Showing 41-50 of 9661 results for "".
Credit Card on File: Benefit or Liability?
https://practicaldermatology.com/topics/practice-management/credit-card-on-file-benefit-or-liability/20422/Think twice before asking patients for a credit card number to keep on file.- CPP Launches Network of Physician-led Medical Aesthetics Clinics Across UShttps://practicaldermatology.com/news/cpp-launches-network-of-physician-led-medical-aesthetics-clinics-across-us/2461442/Cosmetic Physician Partners Inc. ("CPP") is pleased to announce its official launch in the US with the closing of its 10th medical aesthetics clinic. Led by Dr. A. Jay Burns, Dr. Joel L. Cohen, Matt and Kathy Taranto and Dan Schacter, CPP is a partnership designed to provide physician o
- Engineered Human Tissue May Help Study Mosquito Bites, Diseaseshttps://practicaldermatology.com/news/engineered-human-tissue-may-help-study-mosquito-bites-diseases/2461774/Researchers have created engineered human tissue to study mosquito bites and the diseases they transmit. The team led by College of Medicine biomedical researcher Bradley Jay Willenberg with Mollie Jewett (UCF Burnett School of Biomedical Sciences) and Andrew Dickerson (University of Te
- ElderDerm Co-Director Suggests Alternatives for 'Senile' in Diagnoseshttps://practicaldermatology.com/news/ElderDerm-Co-Director-Suggests-Alternatives-Senile-Diagnoses/2474689/The word senile can be avoided in discussing dermatologic diseases, Jaya Manjunath, MSIV, asserted at the ElderDerm 2025 Conference in Washington, DC. Manjunath, a medical student and co-director of the conference along with Practical Dermatology editorial board member Adam Friedm
- Vehicles, Infectious Disease, and Acne Updates from Day 2 at DERM2019https://practicaldermatology.com/news/vehicles-infectious-disease-and-acne-updates-from-day-2-at-derm2019/2460099/The DERM2019 NP/PA CME Conference continued to delight audiences with esteemed faculty presenters, including those who presented Friday, including April Armstrong, David Cohen, Kara Gooding, Joseph Gorelick, Julie Harper, Jayme Heim, George Keough, Leon Kircik, Kristine Kucera, Gilly Munavalli, T
- INTEGUMENT-INFANT: Roflumilast Cream 0.05% Shows Itch and Quality-of-Life Improvements in Infants With ADhttps://practicaldermatology.com/news/integument-infant-roflumilast-cream-005-shows-itch-and-quality-of-life-improvements-in-infants-with-ad/2489033/New data from the INTEGUMENT-INFANT trial showed improvements in caregiver-reported itch, atopic dermatitis symptoms, and quality of life among infants treated with ZORYVE (roflumilast) cream 0.05%, according to findings presented at the American College of Allergy, Asthma & Immunology (ACAAI
- Tapinarof Cream Shows Consistent Efficacy Across Atopic Dermatitis Subgroups in Phase 3 Analysishttps://practicaldermatology.com/news/tapinarof-cream-shows-consistent-efficacy-across-atopic-dermatitis-subgroups-in-phase-3-analysis/2488989/A pooled post hoc analysis of the phase 3 ADORING 1 and ADORING 2 trials found that tapinarof cream, 1% (VTAMA; Organon), demonstrated consistent improvements in disease severity and itch across subgroups of patients with moderate to severe atopic dermatitis (AD), including
- BEACON Study: Brepocitinib Associated with 69% Skin Clearance Rate in Cutaneous Sarcoidosishttps://practicaldermatology.com/news/beacon-brepocitinib-achieves-high-rates-of-skin-clearance-in-cutaneous/2488994/The oral tyrosine kinase 2 (TYK2)/Janus kinase 1 (JAK1) inhibitor brepocitinib significantly improved cutaneous sarcoidosis disease activity compared with placebo in a phase 2 randomized clinical trial published in JAMA Dermatology. Brepocitinib Efficacy and Safety in Cutaneous S
- Analysis: End-of-Dose Effect May Guide Biologic Optimization in Hidradenitis Suppurativahttps://practicaldermatology.com/news/analysis-end-of-dose-effect-may-guide-biologic-optimization-in-hidradenitis-suppurativa/2489005/A response-pattern–guided approach to biologic optimization was associated with improvements in disease severity and flare outcomes among patients with hidradenitis suppurativa (HS) who experienced partial responses to treatment, according to a retrospective cohort study published in JAMA Der
- Air Pollution Linked to Higher Atopic Dermatitis Prevalence in Childrenhttps://practicaldermatology.com/news/air-pollution-linked-to-higher-atopic-dermatitis-prevalence-in-children/2488987/A systematic review and meta-analysis published in JAMA Pediatrics found that exposure to certain ambient air pollutants was associated with higher atopic dermatitis (AD) prevalence and increased outpatient visits among children, although evidence linking pollution to disease incidence or severit